The Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024.
- Revenue
- +3.01%
- EPS
- +223.8%
- Free cash flow
- −12.5%
- Total debt
- −7.64%
Quarter to September 2026, against a year earlier
Follow CC
Alert me
The Chemours Company (CC) Revenue growth
The Chemours Company's revenue growth over the twelve months to 30 September 2026 was 0.10%, down 0.4 percentage points from fiscal 2025 (0.45%). Over the past ten years it has ranged from −16.8% (fiscal 2019) to 27.7% (fiscal 2021); the current reading is higher than 64% of that period. That is below the Specialty Chemicals industry median of 6.39% and below the Basic Materials sector median of 9.54%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 0.45% | 5.32 |
| FY2024 | −4.87% | 6.15 |
| FY2023 | −11.0% | (18.68) |
| FY2022 | 7.66% | (20.03) |
| FY2021 | 27.7% | 37.77 |
| FY2020 | −10.1% | 6.67 |
| FY2019 | −16.8% | (24.11) |
| FY2018 | 7.36% | (7.14) |
| FY2017 | 14.5% | 20.04 |
| FY2016 | −5.54% | 5.58 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 3.01% | 4.50 |
| Jun 2026 | −1.49% | (2.44) |
| Mar 2026 | 0.95% | 3.01 |
| Dec 2025 | −2.06% | (1.20) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| WDFC WD-40 Company compare | 11.0% |
| NGVT Ingevity Corporation compare | 10.6% |
| SCL Stepan Company compare | 10.0% |
| KWR Quaker Houghton compare | 8.68% |
| MTX Minerals Technologies Inc. compare | 4.76% |
| IOSP Innospec Inc. compare | 4.73% |
| FUL H. B. Fuller Company compare | 1.48% |
| CC The Chemours Company | 0.10% |
| STDN Standard Nuclear Inc compare | — |
| Specialty Chemicals industry median | 6.39% |
| Basic Materials sector median | 9.54% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on CC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement